Tag: GPN Vaccines
South Australian-made pneumococcal vaccine to undergo human trials
GPN Vaccines, a South Australian biotech company, has successfully developed a new universal vaccine that targets a pneumonia-causing bacterium.
Developed in collaboration with the University...
SA biotech firm wins State Government grant to trial low-cost pneumococcal vaccine
South Australian biotech company GPN Vaccines has secured a $1 million State Government grant to complete its first-in-human clinical trials for a more effective and lower...
Featured Article
Beyond insights: CRM’s transformative role in sustainable manufacturing
Manufacturing companies worldwide are increasingly gearing up for a significant transformation with environmental sustainability at the centre. This comes amid stronger environmental regulations, a shift in consumer behaviour, and the industrial sector delves deeper into Industry 4.0.
